In a Diabetes Special Issue of The Lancet,researchers have shown that patients with newly diagnosed type 2diabetes who receive early intensive insulin therapy may be able toimprove the function of their insulin-producing β-cells. The therapyregimen has also been associated with the recovering and restoration ofblood glucose control.Type 2 diabetes - commonly known as adult-onset diabetes - is ametabolic disorder characterized by insulin resistance.